Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-22 4:05 pm Purchase | 2024-08-20 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 12,788,710 18.000% | 2,618,922 (+25.75%) | Filing |
| 2024-06-06 1:59 pm Purchase | 2024-03-07 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 10,169,788 17.400% | 44,000 (+0.43%) | Filing |
| 2023-05-26 5:29 pm Purchase | 2023-05-24 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 10,125,788 18.500% | 1,697,683 (+20.14%) | Filing |
| 2023-05-05 4:13 pm Purchase | 2023-04-13 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 8,428,105 19.300% | 8,428,105 (New Position) | Filing |